<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00435097</url>
  </required_header>
  <id_info>
    <org_study_id>colmri-HMO-CTIL</org_study_id>
    <nct_id>NCT00435097</nct_id>
  </id_info>
  <brief_title>Computer Assisted Early Detection of Liver Metastases From fMRI Maps</brief_title>
  <official_title>Computer Assisted Early Detection of Liver Metastases From fMRI Maps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to develop a detailed MRI technique and haemodynamic maps&#xD;
      enabling early detection of colorectal metastases in the liver.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this research, we propose to develop methods and protocols for imaging-based, non-invasive&#xD;
      early detection and diagnosis of colon cancer metastases. Colon cancer is the third most&#xD;
      common cancer worldwide. While it is amenable to surgery if detected early, advanced&#xD;
      carcinomas are usually lethal, with liver metastases being the most common cause of death.&#xD;
      Early and accurate detection of these lesions is recognized as having the potential of&#xD;
      improving survival rates and reducing treatment morbidity. Current diagnostic imaging offers&#xD;
      improved discrimination and sensitivity that can be used for earlier detection of smaller&#xD;
      lesions conducive to curative therapy.&#xD;
&#xD;
      In previous research, we demonstrated the feasibility of fMRI based on hypercapnia and&#xD;
      hyperoxia for monitoring changes in liver perfusion and hemodynamics without contrast agent&#xD;
      administration. The isolation and analysis of areas with significant hemodynamical changes in&#xD;
      images acquired at early phase of tumor development has proven to be a difficult, time&#xD;
      consuming, and potentially unreliable task. Our goal is thus two-fold: 1. use image&#xD;
      processing and machine learning tools on a training set of hemodynamical maps obtained from&#xD;
      well validated tumors to automate the process and improve its discrimination and sensitivity&#xD;
      characteristics, and; 2. implement our method in patients with colorectal liver metastases.&#xD;
      The method can help general radiologists with no image processing training to highlight&#xD;
      undetectable tumors from background noise and increase diagnosis specificity and sensitivity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>Metastatic Colorectal Cancer</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Control group of healthy volunteers&#xD;
&#xD;
          -  Study group: Patients with colon cancer stage III or IV with high suspicion of liver&#xD;
             metastases: raising CEA, suspected lesion in the liver by CT or PET.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to perform MRI.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayala Hubert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abramovitch Rinat, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joskowicz Leo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hebrew University, Jerusalem</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ayala Hubert, MD</last_name>
    <email>ayalah@hadassah.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hadas Lemburg, PhD</last_name>
    <phone>00 972 2 6777572</phone>
    <email>lhadas@hadassah.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Arik Tzukert, DMD</last_name>
      <phone>00 972 2 6776095</phone>
      <email>arik@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Ayala Hubert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rinat Abramovitch, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hebrew University</name>
      <address>
        <city>Jerusalem</city>
        <zip>96000</zip>
        <country>Israel</country>
      </address>
    </facility>
    <investigator>
      <last_name>Leo Joskowicz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <study_first_submitted>February 13, 2007</study_first_submitted>
  <study_first_submitted_qc>February 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2007</study_first_posted>
  <last_update_submitted>February 13, 2007</last_update_submitted>
  <last_update_submitted_qc>February 13, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 14, 2007</last_update_posted>
  <keyword>colon cancer</keyword>
  <keyword>metastatic colorectal cancer</keyword>
  <keyword>MRI</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>Early cancer detection</keyword>
  <keyword>medical image processing</keyword>
  <keyword>machine learning</keyword>
  <keyword>disease modeling</keyword>
  <keyword>Colon Cancer Stage III</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

